BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22836063)

  • 1. Radiation-free weekend rescued! Continuous accelerated irradiation of 7-days per week is equal to accelerated fractionation with concomitant boost of 7 fractions in 5-days per week: report on phase 3 clinical trial in head-and-neck cancer patients.
    Skladowski K; Hutnik M; Wygoda A; Golen M; Pilecki B; Przeorek W; Rutkowski T; Lukaszczyk-Widel B; Heyda A; Suwinski R; Tarnawski R; Maciejewski B
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):741-6. PubMed ID: 22836063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: long-term results of phase III clinical trial.
    Skladowski K; Maciejewski B; Golen M; Tarnawski R; Slosarek K; Suwinski R; Sygula M; Wygoda A
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):706-13. PubMed ID: 17011446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3.
    Terhaard CH; Kal HB; Hordijk GJ
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):62-9. PubMed ID: 15850903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck--a phase III trial from a single institution in India.
    Ghoshal S; Goda JS; Mallick I; Kehwar TS; Sharma SC
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):212-20. PubMed ID: 18343310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer.
    Ishii K; Tashiro M; Hosono M; Fukuda H; Takada Y; Kondo S; Inoue Y; Iguchi H; Kusuki M; Yamane H
    Acta Otolaryngol Suppl; 2004 Oct; (554):62-6. PubMed ID: 15513514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial.
    Overgaard J; Mohanti BK; Begum N; Ali R; Agarwal JP; Kuddu M; Bhasker S; Tatsuzaki H; Grau C
    Lancet Oncol; 2010 Jun; 11(6):553-60. PubMed ID: 20382075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized clinical trial on continuous 7-days-a-week postoperative radiotherapy for high-risk squamous cell head-and-neck cancer: a report on acute normal tissue reactions.
    Suwinski R; Bankowska-Wozniak M; Majewski W; Sowa A; Idasiak A; Ziolkowska E; Windorbska W; Tarnawski R; Skladowski K; Maciejewski B
    Radiother Oncol; 2005 Oct; 77(1):58-64. PubMed ID: 16157401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Split-course accelerated therapy in head and neck cancer: an analysis of toxicity.
    Delaney GP; Fisher RJ; Smee RI; Hook C; Barton MB
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):763-8. PubMed ID: 7790263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized clinical trial on 7-days-a-week postoperative radiotherapy for high-risk squamous cell head and neck cancer.
    Suwiński R; Bańkowska-Woźniak M; Majewski W; Idasiak A; Maciejewski A; Ziółkowska E; Windorbska W; Składowski K; Miszczyk L; Maciejewski B
    Radiother Oncol; 2008 May; 87(2):155-63. PubMed ID: 18342964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancer.
    Zouhair A; Azria D; Pasche P; Stupp R; Chevalier J; Betz M; Mirimanoff RO; Ozsahin M
    Radiother Oncol; 2004 Feb; 70(2):183-8. PubMed ID: 15028406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94).
    Ghadjar P; Simcock M; Studer G; Allal AS; Ozsahin M; Bernier J; Töpfer M; Zimmermann F; Betz M; Glanzmann C; Aebersold DM;
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):524-31. PubMed ID: 21300466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Accelerated radiotherapy with the concomitant-boost technic in patients with squamous cell carcinoma of the head and neck].
    Sanguineti G; Corvò R; Frascio F; Vitale V
    Radiol Med; 1994 Nov; 88(5):650-6. PubMed ID: 7824783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Base-of-tongue carcinoma: treatment results using concomitant boost radiotherapy.
    Mak AC; Morrison WH; Garden AS; Ang KK; Goepfert H; Peters LJ
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):289-96. PubMed ID: 7673016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can concomitant-boost accelerated radiotherapy be adopted as routine treatment for head-and-neck cancers? A 10-year single-institution experience.
    Allal AS; Taussky D; Mach N; Becker M; Bieri S; Dulguerov P
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1431-6. PubMed ID: 15050320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced head and neck carcinoma in women: treatment outcomes may not improve with accelerated hyperfractionated radiotherapy.
    Leborgne F; Leborgne JH; Fowler JF; Zubizarreta E; Mezzera J
    Cancer; 2001 Jun; 91(12):2353-60. PubMed ID: 11413525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised trial of accelerated radiotherapy for localised invasive bladder cancer.
    Horwich A; Dearnaley D; Huddart R; Graham J; Bessell E; Mason M; Bliss J
    Radiother Oncol; 2005 Apr; 75(1):34-43. PubMed ID: 15878099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study.
    Poulsen MG; Denham JW; Peters LJ; Lamb DS; Spry NA; Hindley A; Krawitz H; Hamilton C; Keller J; Tripcony L; Walker Q
    Radiother Oncol; 2001 Aug; 60(2):113-22. PubMed ID: 11439206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoradiation for advanced head and neck cancer: potential for improving results to match those of current treatment modalities for early-stage tumors--long-term results of hyperfractionated chemoradiation with carbogen breathing and anemia correction with erythropoietin.
    Villar A; Martinez JC; de Serdio JL
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1382-8. PubMed ID: 18037586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.